Mild Cognitive Impairment in Young Onset Parkinson Disease
Objective: To identify the prevalence of Parkinson disease mild cognitive impairment (PD-MCI) in a group of persons with young onset Parkinson disease (YOPD) consecutively referred…Pathological role of GBA2 in GBA1-related disorder
Objective: This study was performed to determine the pathological role of the non-lysosomal β-Glucosidase (GBA2) in the CNS in Gaucher’s disease (GD) and GBA1-related Parkinson's…Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease
Objective: Verification of the previously reported association between chronic use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk of Parkinson’s disease (PD),…Translation, validation, diagnostic accuracy and reliability of a Parkinson´s disease screening questionnaire in three countries in Africa: A progress report and preliminary data
Objective: To translate and adapt the PD screening questionnaire into French and Arabic for use in Africa. To determine the diagnostic accuracy of the English,…Structural changes in non-manifesting GBA mutation carriers and GBA mutation carriers with Parkinson’s disease
Objective: We aimed to investigate whether GBA mutations are associated with structural abnormalities in a cohort of GBA mutation carriers with and without manifested PD.…Karl Marx, Rosa Luxemburg, and Deep Brain Stimulation: is there a connection?
Objective: To investigate possible reasons behind some practices of deep brain stimulation (DBS) hardware providers. Background: The global success of DBS in movement disorders has…Does Deep Brain Stimulation in Parkinson’s Disease Change Disease Progression in the Long Run?
Objective: This is one of the first studies investigating the progression of disease and mortality of patients with Parkinson’s Disease (PD) 8-15 years after Deep…PARKMIM: A Transversal Pilot Study on Hemihypomimia in Parkinson Disease
Objective: To describe the prevalence of facial asymmetry due to hemihypomimia in a non fluctuating Parkinson disease (PD) cohort and compare it to age-matched controls.…The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease
Objective: To assess the relationship between individual items from the Neuropsychiatric Inventory and five cognitive domains in patients with Parkinson's disease (PD) and normal cognitive…Relationships of gender, care models, and neuropsychiatric symptoms in Parkinson’s disease
Objective: To examine relationships among gender, care models, and presence and management of neuropsychiatric symptoms of Parkinson’s disease (PD). Background: Neuropsychiatric symptoms such as depression…
- « Previous Page
- 1
- …
- 231
- 232
- 233
- 234
- 235
- …
- 425
- Next Page »